REG - Macquarie Bank Ltd - MBL Covered Bond Programme H12023 results

MacquarieAnnouncement

02/11/2022 08:15

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20221102:nRSB0127Fa&default-theme=true

RNS Number : 0127F  Macquarie Bank Limited  02 November 2022

Announcement

Publication of Prospectus Supplement

The following prospectus supplement (the Supplement) has been approved by the
Financial Conduct Authority and is available for viewing:

Macquarie Bank Limited (MBL) Supplement dated 1 November 2022 to the AUD
10,000,000,000 MBL Covered Bond Programme prospectus dated 10 June 2022 (the
Prospectus)

To view the full document, please paste the following URL into the address bar
of your browser.

https://www.macquarie.com/au/en/investors/debt-investors/secured-funding.html
(https://www.macquarie.com/au/en/investors/debt-investors/secured-funding.html)

In addition, MBL has published a copy of the MBL Interim Financial Report for
the Half year ended 30 September 2022 (the Interim Financial Report) on the
Macquarie website at http://www.macquarie.com (http://www.macquarie.com)

 

To view the full document, please paste the following URL into the address bar
of your browser:

 

http://www.macquarie.com/au/about/investors/reports
(http://www.macquarie.com/au/about/investors/reports)

A copy of each of the Supplement and the Interim Financial Report has also
been submitted to the National Storage Mechanism and will shortly be available
for inspection at: https://data.fca.org.uk/#/nsm/nationalstoragemechanism
(https://data.fca.org.uk/#/nsm/nationalstoragemechanism)

For further information, please contact:

 

Macquarie Bank Limited

Mr. Angus Cameron

Level 6, 50 Martin Place

Sydney NSW 2000

Australia

 

Telephone : +61 2 8232 3333

Fax : +61 2 8232 4227

Email: Angus.Cameron@macquarie.com

 

DISCLAIMER ‑ INTENDED ADDRESSEES

Please note that the information contained in the Supplement may be addressed
to and/or targeted at persons who are residents of particular countries
(specified in the Prospectus) only and is not intended for use and should not
be relied upon by any person outside these countries and/or to whom the offer
contained in the Prospectus, as supplemented, is not addressed.  Prior to
relying on the information contained in the Prospectus, as supplemented, you
must ascertain from the Prospectus, as supplemented, whether or not you are
part of the intended addressees of the information contained therein.

Your right to access this service is conditional upon complying with the above
requirement.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  PSPBTBTTMTJMMPT